소양감과 전신 홍반을 동반한 Lenalidomide에 의한 약물 발진
- Alternative Title
- A Case of Lenalidomide-induced Drug Eruption Presenting as Pruritus and Erythema Covering the Whole Body
- Abstract
- Lenalidomide is an immunomodulatory drug used for the treatment of multiple myeloma. Several cases of hematological, gastrointestinal, and cutaneous side effects have been reported for this drug. A 67-year-old patient with multiple myeloma had initially been treated with bortezomib, but the treatment was discontinued due to neurological side effects. The chemotherapeutic regimen of this patient was changed to lenalidomide. Ten days later, erythema and pruritus developed on the entire body. The lenalidomide dose was subsequently reduced and the patient was additionally treated with topical steroids. Because lenalidomide is supplied by the Korean Orphan Drug Center, physicians have limited experience with the drug, and hence, its side effects tend to be underestimated. In addition, the Korean literature lacks reports on such cases. We describe herein a case of lenalidomide-induced drug eruption presenting as a pruritic rash covering the whole body.
- All Author(s)
- J. Y. Shin
; K. R. Hong
; J. E. Kim
; S. H. Lee
; Y. L. Park
- Issued Date
- 2019
- Type
- Article
- Keyword
- Drug eruption; Erythema; Pruritus
- Publisher
- 대한피부과학회
Korean Dermatological Association
- ISSN
- 0494-4739
; 2713-7627
- Citation Title
- 대한피부과학회지
Korean Journal of Dermatology
- Citation Volume
- 57
- Citation Number
- 3
- Citation Start Page
- 149
- Citation End Page
- 151
- Language(ISO)
- kor
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/3092
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.